Dec. 23 at 8:06 PM
$XWEL @777Dog Thanks for pointing this discussion on biothreats! I've got into XWEL a few months and now looking to increase my shares. I was counting on the upcoming soccer world cup and other big events in the US and xpresCheck should make it big
Anyways, I was looking at their recent 10-Q and it says "In February 2025, the program was extended through a three-year contract with a total base value of
$22.2 million over three years, and a maximum ceiling value of
$24.8 million within the same timeframe."
I belive this is XWEL's share (from the news from that time the funding involved is much larger; may be Ginkgo takes the rest). Am I understanding this right that over the next 3 years, they can get an average of only around
$2 million per quarter (
$24.8 m max over 3 years), which they already made last quarter? I was expecting they would make much more next year but on average it seems they cannot make more than
$2 million. If that's the case, there's an upper ceiling to their revenues
